Notably, although numerous preclinical studies confirm that resveratrol significantly improves various pathological indicators of diabetic kidney disease (such as creatinine, blood urea nitrogen, and urine albumin-to-creatinine ratio) [219,220], the results of existing human clinical trials on resveratrol intervention for DKD exhibit heterogeneity. This evidence concerns the gene ALB and diabetic kidney disease.